MktsMarkets

GoodRx Holdings, Inc.
NASDAQ: GDRXKey statistics
GDRX News
Stories mentioning GDRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 194,006 | 194,785 | 196,028 | 203,070 | 202,970 | 198,583 | 195,251 | 200,610 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 30,177 | 28,939 | 31,012 | 29,933 | 31,142 | 31,739 | 30,139 | 30,854 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 14,009 | 22,683 | 14,620 | 26,809 | 23,380 | 18,180 | 20,407 | 19,878 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 0.00 | 694.00 | 0.00 | (2,660) | 0.00 | |||
| Pretax Income | 5,639 | 14,193 | 6,100 | 19,577 | 16,668 | 11,409 | 8,112 | 11,646 |
| Tax Provision | 4,470 | 8,768 | 4,981 | 6,734 | 5,616 | 4,669 | 4,147 | 4,952 |
| Net Income (Loss) | 1,169 | 5,425 | 1,119 | 12,843 | 11,052 | 6,740 | 3,965 | 6,694 |
| Earnings Per Share (Basic) | 0.00 | 0.02 | 0.00 | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 |
| Earnings Per Share (Diluted) | 0.00 | 0.02 | 0.00 | 0.04 | 0.03 | 0.02 | 0.01 | 0.02 |
| Weighted Average Shares Outstanding (Basic) | 340,531 | 356,327 | 346,776 | 356,623 | 379,196 | 385,737 | 379,667 | 376,254 |
| Weighted Average Shares Outstanding (Diluted) | 341,424 | 356,973 | 347,810 | 357,159 | 379,656 | 392,172 | 388,504 | 384,732 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GDRX
GoodRx Holdings, Inc. (NASDAQ: GDRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol GDRX. It last traded at $3.56 (Nov 13, 2026, 4:00 PM ET), up 1.4% on the day. That gives GoodRx a market capitalisation of $1.2B and a price-to-earnings ratio of 74.7.
Over the past 52 weeks GDRX has traded between $1.77 and $3.89.
Revenue for the quarter ended Mar 31, 2026 was $194.0M; net income $1.2M. Revenue was down 4.4% from $203.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $194.0M | $1.2M | 0.6% |
| Dec 31, 2025 | $194.8M | $5.4M | 2.8% |
| Sep 30, 2025 | $196.0M | $1.1M | 0.6% |
| Jun 30, 2025 | $203.1M | $12.8M | 6.3% |
From GoodRx’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…